The verified answer
As of Oct 2026, DEPLOY verifies Remebot: 2 models, 2 deployments across 1 region, $65.8M raised. 1 source back the record.
CategorySurgical robots
Overview
Remebot is a Chinese surgical robotics company (Beijing Baihui Weikang Technology Co., Ltd. / 柏惠维康) developing neurosurgical and dental robots for stereotactic procedures. Spun out of Beihang University research led by Wang Tianmiao, the Remebot system became China's first NMPA-approved neurosurgical robot in 2018. Its RM-50 cerebral hemorrhage robot and dental robot have been deployed across 300+ hospitals in 31 provinces, performing over 30,000 clinical operations
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- None on file
Valuation of record
Company-claimedPriced roundSeries D post-money
Key facts
Robot
Regulatory
Applications
Product
Company
CEO
Founder
Research lead
NMPA approvals
Cumulative funding
Clinical operations
Precision
Data & sources
Web sources
1
1 source backing this record.View all →
Models (2)
View all models →Current platform
RM-50
The RM-50 is Remebot's cerebral hemorrhage surgical robot, featuring a 1-meter-tall frame with a robotic arm for minimally invasive neurosurgical procedures. It constructs 3D models of the brain to guide hematoma drainage through a 1mm-diameter hole. Received NMPA certification in 2022 and has been deployed at over 100 hospitals
Current platform
Remebot
China's first NMPA-approved neurosurgical robot (Class III, 2018). Features a six-axis robotic arm with CT/MRI-compatible visual imaging system, AI-based image identification, and 0.5mm positioning precision guided by an independent optical navigation system. Used for brain biopsy, hematoma drainage, and deep brain stimulation electrode implantation across 300+ hospitals
Remebot on the deployment map
View the global map2 verified deployments across 1 region, newest verified Jan 2022. Explore where Remebot's robots are operating, by place and type.
View the full Remebot deployment record →
Relationships
Current leadership (2)
- Wang Tianmiao (王田苗) Research Lead & Co-developersecondary-verified
- Da Liu (刘达) Founder & CEO, CEO & Foundersecondary-verified
Founders (1)
- Da Liu (刘达)cofounderno longer at company
Safety record
No incidents on record for Remebot.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- Remebot2 deployments
Recent coverage
Remebot in third-party press
Remebot | Neurosurgical Robotic System Development Company of the Year in Asia 2025 - MedTech Outlook
Kazakhstan Takes Leap Forward with First Advanced Neurosurgical Robot in Karaganda - Caspianpost.com
Kazakhstan's Karaganda set to perform robotic brain surgeries - Qazinform
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
Financial state
- Total funding
- $65.8M
- Reporting basis
- private_reported
- Lifecycle stage
- growth
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Series D2020-12-16
$66M(reported) · $790M post
Investors: Xin Ding Capital, Zhongguancun Longmen Investment (lead), China Capital Management, Chord Capital, Heyin Capital, MPC
Timeline
Every recorded move in Remebot’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Funding roundSeries D funding round
2020-12-16Series D raising $65820000
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 27, 2026
Added to the verified registry
- Deployment verifiedVerifiedJan 1, 2022
RM-50 at Beijing, China
- Deployment verifiedVerifiedJan 1, 2018
Remebot at Beijing, China
Sources (1)
Common questions
What is Remebot?
What does Remebot make?
Who competes with Remebot?
Who is the CEO of Remebot?
Where is Remebot headquartered?
How much funding has Remebot raised?
Where does Remebot operate robots?
How many robots has Remebot deployed?
Is Remebot a top robotics company?
When was Remebot founded?
Is Remebot safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Remebot.Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
In the press
Recent coverage mentioning Remebot from third-party publications. Automatically surfaced; not part of the verified registry record.
Remebot | Neurosurgical Robotic System Development Company of the Year in Asia 2025 - MedTech Outlook
<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE5sTm1KU29yU0sxS01wdnRpSW5ZVDVnWm8xNGZSVG5wbWM2Q3dHNkJ6V0VFbXVZeENFeFo3RE5JQ0ZHa2ZiT1l4MDlybjhlV1kwcERPWQ?oc=5"…
Kazakhstan Takes Leap Forward with First Advanced Neurosurgical Robot in Karaganda - Caspianpost.com
<a…
Kazakhstan's Karaganda set to perform robotic brain surgeries - Qazinform
<a…
Robot assisted stereotactic surgery improves hematoma evacuation in intracerebral hemorrhage compared to frame based method - Nature
<a…
Robot-assisted implant surgery ‘significantly enhances accuracy and clinical safety’ - Dentistry.co.uk
<a…
Key patents indicate future trajectory for surgical robotics and reveal necessary IP management insights - IAM Patent
<a…
Company Profile — Beijing Baihui Weikang Technology Co., Ltd.
Official company profile: founded 2010, 300+ hospitals served, 30,000+ clinical operations, first NMPA Class III neurosurgery robot approval in 2018, RM-50 cerebral hemorrhage…
Medical robots improve quality of life
China Daily reports on Remebot's RM-50 cerebral hemorrhage robot, certified at over 100 hospitals and used in over 30,000 surgeries, showcased at the 2022 World Robot Conference.
A pioneer in neurosurgical robots
Nature profiles Remebot as China's first NMPA-approved neurosurgical robot, developed at Beihang University by Wang Tianmiao's team and commercialized by Da Liu through Beijing…
A pioneer in neurosurgical robots - Nature
<a…
New technologies and new medical reforms bring new opportunities for science and technology medicine
Liu Da, CEO of Remebot (Baihui Weikang), speaks at the Yanqi Health Talk on technology and medical industry, discussing Chinese medical robots and the future of AI in healthcare.
Remebot is China's first neurosurgery robot - CNET
<a…
Machine-readable surfaces
- Markdown mirror: /companies/remebot.md
- RSS feed: /companies/remebot/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/366635c3-c5c3-4b1f-bdb3-f4ce77157a22
- Revision history: /companies/remebot/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
Video
For more: https://news.cgtn.com/news/2021-11-08/5G-powered-medical-Remebot-performs-remote-brain-surgery-in-60-seconds-151tj2h2CXu/index.html Experts performed a 5G remote brain surgery at Beijing Tiantan Hospital on N
The human brain is one of the most dangerous regions for surgery. Any tiny mistake may cause a threat to life. Now, with the assistance of Remebot, surgeons can
Remebot, the most successfull neurosurgical robot system in China
Beijing Baihui Weikang Technology Co., Ltd. was founded in 2010, is a national high-tech enterprise specializing in the research and development of surgical rob
Heat Index
Category contender75/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Remebot draws attention at the 43rd percentile but verifies reality at the 26th percentile among surgical robots. Hype Gap +17.7, 18th widest among surgical robots.
6-month trend
Analysis
Clean safety record across 2 verified deployments. Deployment footprint remains limited relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Oct 2, 2026